Section 402(g) of the Federal Food,
Drug, and Cosmetic Act (the act) (21 U.S.C. 342 (g)) gives the Food
and Drug Administration (FDA) explicit authority to issue a rule
establishing Current Good Manufacturing Practice for dietary
supplements. Section 402(g)(1) of the act states that a dietary
supplement is adulterated if "it has been prepared, packed, or held
under conditions that do not meet current good manufacturing
practice regulations." Section 402(g)(2) of the act authorizes FDA
to, by regulation, "prescribe good manufacturing practices for
dietary supplements." Under section 701(a) of the act (21 U.S.C.
371), FDA may issue regulations necessary for the efficient
enforcement of the act.
Records are an indispensable
component of CGMP. The records required by this final rule provide
the foundation for the planning, control, and improvement processes
that constitute a quality control system. Implementation of these
processes in a manufacturing operation serves as the backbone to
CGMP. The records will show what is to be manufactured; what was,
in fact, manufactured; and whether the controls that the
manufacturer put in place to control the identity, purity,
strength, and composition and limits on contaminants and to prevent
adulteration were effective. Further, records will show whether and
what deviations from control processes occurred, facilitate
evaluation and corrective action concerning these deviations
(including, where necessary, whether associated batches of product
should be recalled from the marketplace), and enable a manufacturer
to assure that the corrective action was effective. In addition, by
requiring records, the agency will be able to ensure that firms
follow CGMPs so that they ensure the quality of their dietary
supplements during manufacturing, packaging, labeling, or holding
operations. The final rule establishes the minimum manufacturing
practices necessary to ensure that dietary supplements are
manufactured, packaged, labeled, or held in a manner that will
ensure the quality of the dietary supplements during manufacturing,
packaging, labeling or holding operations.
$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected
Jonnalynn Capezzuto
3018274659
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.